These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36521891)

  • 1. Increasing the availability of long-acting reversible contraception and medical abortion in primary care: the Australian Contraception and Abortion Primary Care Practitioner Support Network (AusCAPPS) cohort study protocol.
    Mazza D; James S; Black K; Taft A; Bateson D; McGeechan K; Norman WV
    BMJ Open; 2022 Dec; 12(12):e065583. PubMed ID: 36521891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What do Australian primary care clinicians need to provide long-acting reversible contraception and early medical abortion? A content analysis of a virtual community of practice.
    Srinivasan S; James SM; Kwek J; Black K; Taft AJ; Bateson D; Norman WV; Mazza D
    BMJ Sex Reprod Health; 2024 Jul; ():. PubMed ID: 38960413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving rural and regional access to long-acting reversible contraception and medical abortion through nurse-led models of care, task-sharing and telehealth (ORIENT): a protocol for a stepped-wedge pragmatic cluster-randomised controlled trial in Australian general practice.
    Mazza D; Shankar M; Botfield JR; Moulton JE; Chakraborty SP; Black K; Tomnay J; Bateson D; Church J; Laba TL; Kasza J; Norman WV
    BMJ Open; 2023 Mar; 13(3):e065137. PubMed ID: 36948556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
    Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
    BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial longitudinal follow-up protocol.
    Mazza D; Amos N; Watson CJ; McGeechan K; Haas M; Peipert JF; Lucke J; Taft A; McNamee K; Black KI
    BMJ Open; 2020 Sep; 10(9):e035895. PubMed ID: 32963063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-design of a nurse-led model of care to increase access to medical abortion and contraception in rural and regional general practice: A protocol.
    Moulton JE; Mazza D; Tomnay J; Bateson D; Norman WV; Black KI; Subasinghe AK
    Aust J Rural Health; 2022 Dec; 30(6):876-883. PubMed ID: 36264024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do women need to know about long-acting reversible contraception? Perspectives of women from culturally and linguistically diverse backgrounds.
    Liu R; Mazza D; Li CK; Subasinghe AK
    Health Promot J Austr; 2024 Apr; 35(2):276-284. PubMed ID: 37161644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustainable and effective methods to increase long-acting reversible contraception uptake from the ACCORd general practice trial.
    Taft A; Watson CJ; McCarthy E; Black KI; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Mazza D
    Aust N Z J Public Health; 2022 Aug; 46(4):540-544. PubMed ID: 35557481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of long-acting reversible contraception after telemedicine delivered abortion during Covid-19.
    Dixon A; Reynolds-Wright JJ; Cameron ST
    Eur J Contracept Reprod Health Care; 2022 Aug; 27(4):284-288. PubMed ID: 35713651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding community pharmacists' scope of practice in relation to contraceptive counselling and referral: a protocol for a pragmatic, stepped-wedge, cluster randomised trial (ALLIANCE).
    Mazza D; Assifi AR; Hussainy SY; Bateson D; Johnston S; Tomnay J; Kasza J; Church J; Grzeskowiak LE; Nissen L; Cameron ST
    BMJ Open; 2023 Aug; 13(8):e073154. PubMed ID: 37652588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interactive website to aid young women's choice of contraception: feasibility and efficacy RCT.
    Stephenson J; Bailey JV; Blandford A; Brima N; Copas A; D'Souza P; Gubijev A; Hunter R; Shawe J; Rait G; Oliver S
    Health Technol Assess; 2020 Nov; 24(56):1-44. PubMed ID: 33164729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associations of prescribing of long-acting reversible contraception by general practitioner registrars: a secondary analysis of ReCEnT data.
    Turner R; Tapley A; Sweeney S; Davey A; Holliday E; van Driel M; Henderson K; Ball J; Morgan S; Spike N; FitzGerald K; Magin P
    BMJ Sex Reprod Health; 2020 Jul; 46(3):218-225. PubMed ID: 31964777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Pediatricians Provide Long-Acting Reversible Contraception?
    Norris AH; Pritt NM; Berlan ED
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting long-acting reversible contraception among post-abortion clients with a provider-comparison intervention: a cluster randomized controlled trial in Nepal.
    Barofsky J; Spring H; Gartoulla P; Shrestha R; Sapkota S; McElwee E; Church K; Datta S; Livingston K
    BMC Public Health; 2024 Jul; 24(1):1903. PubMed ID: 39014384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
    Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
    Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'We're kidding ourselves if we say that contraception is accessible': a qualitative study of general practitioners' attitudes towards adolescents' use of long-acting reversible contraceptives (LARC).
    Duncan R; Paterson H; Anderson L; Pickering N
    J Prim Health Care; 2019 Jul; 11(2):138-145. PubMed ID: 32171356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Long-Acting Reversible Contraception Knowledge, Training, and Provider Concerns Predict Referrals and Placement.
    Thompson CM; Broecker J; Dade M
    J Am Osteopath Assoc; 2019 Nov; 119(11):725-734. PubMed ID: 31657827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.